North America Drug Delivery Devices Market Outlook to 2017

Summary
GlobalData's new report,  North America Drug Delivery Devices Market Outlook to 2
017 provides key market data on the North America Drug Delivery Devices market  Ca
nada and United States. The report provides value (USD million) data for all the
market categories  Central Venous Catheters, Infusion Systems, Metered Dose Inha
ler Devices and Needle Free Injections. The report also provides company shares
and distribution shares data for each of the aforementioned market categories. T
he report is supplemented with global corporate-level profiles of the key market
participants.
This report is built using data and information sourced from proprietary databas
es, primary and secondary research and in-house analysis by GlobalData's team of
industry experts.
Scope
- Countries covered include Canada and United States.
- Market size and company share data for Drug Delivery Devices market categories
 Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Ne
edle Free Injections.
- Annualized market revenues (USD million) data for each of the market categorie
s in each of the country. Data from 2003 to 2010, forecast forward for 7 years t
o 2017.
- 2010 company shares and distribution shares data for each of the market catego
ries and countries.
- Global corporate-level profiles of key companies operating within the North Am
erica Drug Delivery Devices market..
- Key players covered include GlaxoSmithKline plc, Hospira, Inc., CareFusion Cor
poration, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc.
and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segme
nts poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the North Ame
rica Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments e
xpected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of p
roduct distribution  Identify, understand and capitalize.

for more detail you can click here http://www.ordermarketreports.com/product_inf

o.php?products_id=1175
Website http://www.ordermarketreports.com/
1.1 List of Tables
Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-201
7 12
Table 2: Drug Delivery Devices, North America, Overall Revenue ($m), 2003-2017 1
4
Table 3: Drug Delivery Devices, North America, Cross-Category Analysis, 2003-201
7 15
Table 4: Drug Delivery Devices, North America, Overall Revenue ($m), Historic, 2
003-2010 17
Table 5: Drug Delivery Devices, North America, Overall Revenue ($m), Forecast, 2
010-2017 19
Table 6: Drug Delivery Devices, North America, Category Volume (Units), 2003-201
7 20
Table 7: Drug Delivery Devices, North America, Category Volume (Units), Historic
, 2003-2010 22
Table 8: Drug Delivery Devices, North America, Category Volume (Units), Forecast
, 2010-2017 24
Table 9: Drug Delivery Devices, North America, Company share by Revenue ($m), 20
09-2010 26
Table 10: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017
28
Table 11: Drug Delivery Devices, United States, Overall Revenue ($m), Historic,
2003-2010 30
Table 12: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast,
2010-2017 32
Table 13: Drug Delivery Devices, United States, Category Volume (Units), 2003-20
17 33
Table 14: Drug Delivery Devices, United States, Category Volume (Units), Histori
c, 2003-2010 35
Table 15: Drug Delivery Devices, United States, Category Volume (Units), Forecas
t, 2010-2017 37
Table 16: Central Venous Catheters, United States, Distribution Share by Revenue
($m), 2009-2010 38
Table 17: Infusion Systems, United States, Distribution Share by Revenue ($m), 2
009-2010 38
Table 18: Metered Dose Inhaler Devices, United States, Distribution Share by Rev
enue ($m), 2009-2010 39
Table 19: Needle Free Injections, United States, Distribution Share by Revenue (
$m), 2009-2010 39
Table 20: Drug Delivery Devices, United States, Company Share by Revenue ($m), 2
009-2010 41
Table 21: Central Venous Catheters, United States, Company Share by Revenue ($m)
, 2009-2010 43
Table 22: Infusion Systems, United States, Company Share by Revenue ($m), 2009-2
010 45
Table 23: Metered Dose Inhaler Devices, United States, Company Share by Revenue
($m), 2009-2010 46
Table 24: Needle Free Injections, United States, Company Share by Revenue ($m),
2009-2010 48
Table 25: Drug Delivery Devices, Canada, Overall Revenue ($m), 2003-2017 50
Table 26: Drug Delivery Devices, Canada, Overall Revenue ($m), Historic, 2003-20
10 52
Table 27: Drug Delivery Devices, Canada, Overall Revenue ($m), Forecast, 2010-20
17 54
Table 28: Drug Delivery Devices, Canada, Category Volume (Units), 2003-2017 55
Table 29: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2003
-2010 57
Table 30: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2010
-2017 59
Table 31: Central Venous Catheters, Canada, Distribution Share by Revenue ($m),
2009-2010 60
Table 32: Infusion Systems, Canada, Distribution Share by Revenue ($m), 2009-201
0 60
Table 33: Metered Dose Inhaler Devices, Canada, Distribution Share by Revenue ($
m), 2009-2010 61
Table 34: Needle Free Injections, Canada, Distribution Share by Revenue ($m), 20
09-2010 61
Table 35: Drug Delivery Devices, Canada, Company Share by Revenue ($m), 2009-201
0 63
Table 36: Central Venous Catheters, Canada, Company Share by Revenue ($m), 2009-
2010 65
Table 37: Infusion Systems, Canada, Company Share by Revenue ($m), 2009-2010 67
Table 38: Metered Dose Inhaler Devices, Canada, Company Share by Revenue ($m), 2
009-2010 68
Table 39: Needle Free Injections, Canada, Company Share by Revenue ($m), 2009-20
10 70
Table 40: Drug Delivery Devices Market Pipeline Products 83
Table 41: CarePoint Partners Acquires Premier Infusion 87
Table 42: SurModics Plans The Sale Of SurModics Pharmaceuticals 88
Table 43: BTG International To Acquire Biocompatibles 89
Table 44: Nordson Completes Acquisition Of Micromedics 91
Table 45: Cardinal Health Sells 13.7% Stake In Carefusion 92
Table 46: Cellectis Acquires Cyto Pulse Sciences 93
Table 47: InfuSystem Enters Into Distribution Agreement With Poppy Pocket 94
Table 48: Radius Healthe Enters Into Collaboration Agreement With 3M Drug Delive
ry Systems 95
Table 49: Eli Lilly Enters Into Collaboration With Medtronic 96
Table 50: West Pharmaceutical Enters Into Agreement With CareFusion 97
Table 51: Nile Therapeutics Enters Into An Agreement With Medtronic 98
Table 52: Hospira Enters Into An Agreement With Smiths Medical 99
Table 53: USD to Local Currency, North America, Average Exchange Rate 2003-2010
123
for more detail you can click here http://www.ordermarketreports.com/product_inf
o.php?products_id=1175
Website http://www.ordermarketreports.com/
1.2 List of Figures
Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-20
17 12
Figure 2: Drug Delivery Devices, North America, Overall Revenue ($m), 2003-2017
13
Figure 3: Drug Delivery Devices, North America, Cross-Category Analysis, 2003-20
17 15
Figure 4: Drug Delivery Devices, North America, Overall Revenue ($m), Historic,
2003-2010 16
Figure 5: Drug Delivery Devices, North America, Overall Revenue ($m), Forecast,
2010-2017 18
Figure 6: Drug Delivery Devices, North America, Category Volume (Units), 2003-20
17 20
Figure 7: Drug Delivery Devices, North America, Category Volume (Units), Histori
c, 2003-2010 21
Figure 8: Drug Delivery Devices, North America, Category Volume (Units), Forecas
t, 2010-2017 23
Figure 9: Drug Delivery Devices, North America, Company share (%), 2010 25
Figure 10: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017
27
Figure 11: Drug Delivery Devices, United States, Overall Revenue ($m), Historic,
2003-2010 29
Figure 12: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast,
2010-2017 31
Figure 13: Drug Delivery Devices, United States, Category Volume (Units), 2003-2
017 33
Figure 14: Drug Delivery Devices, United States, Category Volume (Units), Histor
ic, 2003-2010 34
Figure 15: Drug Delivery Devices, United States, Category Volume (Units), Foreca
st, 2010-2017 36
Figure 16: Drug Delivery Devices, United States, Company Share (%), 2010 40
Figure 17: Central Venous Catheters, United States, Company Share (%), 2010 42
Figure 18: Infusion Systems, United States, Company Share (%), 2010 44
Figure 19: Metered Dose Inhaler Devices, United States, Company Share (%), 2010
46
Figure 20: Needle Free Injections, United States, Company Share (%), 2010 47
Figure 21: Drug Delivery Devices, Canada, Overall Revenue ($m), 2003-2017 49
Figure 22: Drug Delivery Devices, Canada, Overall Revenue ($m), Historic, 2003-2
010 51
Figure 23: Drug Delivery Devices, Canada, Overall Revenue ($m), Forecast, 2010-2
017 53
Figure 24: Drug Delivery Devices, Canada, Category Volume (Units), 2003-2017 55
Figure 25: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 200
3-2010 56
Figure 26: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 201
0-2017 58
Figure 27: Drug Delivery Devices, Canada, Company Share (%), 2010 62
Figure 28: Central Venous Catheters, Canada, Company Share (%), 2010 64
Figure 29: Infusion Systems, Canada, Company Share (%), 2010 66
Figure 30: Metered Dose Inhaler Devices, Canada, Company Share (%), 2010 68
Figure 31: Needle Free Injections, Canada, Company Share (%), 2010 69
Figure 32: GlaxoSmithKline plc, Company Share (%), North America Drug Delivery D
evices Market, 2010 71
Figure 33: Hospira, Inc., Company Share (%), North America Drug Delivery Devices
Market, 2010 72
Figure 34: CareFusion Corporation, Company Share (%), North America Drug Deliver
y Devices Market, 2010 73
Figure 35: Boehringer Ingelheim GmbH, Company Share (%), North America Drug Deli
very Devices Market, 2010 74
Figure 36: AstraZeneca PLC, Company Share (%),North America Drug Delivery Device
s Market, 2010 75
Figure 37: Baxter International Inc., Company Share (%), North America Drug Deli
very Devices Market, 2010 76